Sample6 moves closer to pathogen detection tech commercialisation

By Joseph James Whitworth

- Last updated on GMT

Related tags Food

Sample6 funding to commercialise pathogen tech
Sample6 funding to commercialise pathogen tech
Sample6 has secured $11m in funding to help commercialise its first products to detect pathogens in food processing environments.

Sample6 DETECT/L is a diagnostic assay and is designed to identify Listeria contamination.

Sample6 CONTROL is a software platform, which can be used to plan, execute, remediate and analyze food safety programs.

The firm said it provides the first synthetic-biology based bacteria diagnostic system that allows for enrichment-free detection and remediation of pathogens in less than eight hours.

Series B financing was led by Canaan Partners with Cultivian Sandbox and Series A lead investor Flybridge Capital Partners.

Sample6 DETECT and Sample6 CONTROL are expected to be available in the first half of 2014.

“We are poised to bring to market our diagnostic and data analytics solutions that have the power to radically change, at first, the food industry’s safety processes – taking a detection and remediation process that takes days down to one that takes hours,”​ said Tim Curran, CEO of Sample6.

Related topics Food Safety & Quality

Related news

Show more

Follow us


View more